Glaukos(GKOS.US)

Event Tracking

Nov26

Glaukos Corporation CFO Reports Sale of Common Stock

22:01

Nov21

Glaukos President and COO Disposes of Company Common Stock

00:56

Nov13

Piper Sandler Maintains Buy Rating on Glaukos

11:52

Nov10

Glaukos Corporation Unveils Growth Strategy for Eye Disease Treatments

12:17

Nov6

Brown Capital Management Reduces Holdings in Glaukos Corporation

12:08

Oct31

Glaukos Develops and Approves Epioxa

14:16

Schedules & Filings

Schedules

Filings

Oct29

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 133.54 M, Net Income -16.23 M, EPS -0.2827

Jul30

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 124.12 M, Net Income -19.66 M, EPS -0.3436

Apr30

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 106.66 M, Net Income -18.15 M, EPS -0.3203

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change